2016
DOI: 10.18596/jotcsa.30880
|View full text |Cite
|
Sign up to set email alerts
|

Production and Drug Release Assesment of Melatonin Loaded Alginate/Gum Arabic Beads

Abstract: Melatonin containing alginate-gum arabic beads were produced by ionotropic gelation. The most suitable alginate-gum arabic ratio for bead production was optimized. To the optimized beads the loading of changing amounts of melatonin was conducted to produce the beads with the best melatonin entrapment and release. Entrapment efficiency of the beads as melatonin carrier was calculated to be approximately 70%. Release profiles of melatonin from the beads were generated using in vitro gastric fluid (pH 1.5) and in… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
3
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 14 publications
0
3
0
Order By: Relevance
“…Most trials on hydrogels for the treatment of cancer have investigated the injection of hydrogels into mice [ 22 , 23 , 24 ]. A series of injectable and cross-linked hydrogels using biocompatible and carbohydrate-based polymers such as quaternized chitosan, hyaluronic acid, fucoidan, and poly-ethylene glycol have been developed as nanocarriers for the delivery of therapeutic agents [ 25 , 26 , 27 , 28 , 29 , 30 , 31 , 32 ]. However, hydrogels remain in the injection site for a certain period of time, which may promote inflammation and other side effects [ 33 , 34 ].…”
Section: Introductionmentioning
confidence: 99%
“…Most trials on hydrogels for the treatment of cancer have investigated the injection of hydrogels into mice [ 22 , 23 , 24 ]. A series of injectable and cross-linked hydrogels using biocompatible and carbohydrate-based polymers such as quaternized chitosan, hyaluronic acid, fucoidan, and poly-ethylene glycol have been developed as nanocarriers for the delivery of therapeutic agents [ 25 , 26 , 27 , 28 , 29 , 30 , 31 , 32 ]. However, hydrogels remain in the injection site for a certain period of time, which may promote inflammation and other side effects [ 33 , 34 ].…”
Section: Introductionmentioning
confidence: 99%
“…We have been interested in the development of dosage form products, which mimic the physiologically secreted high MLT levels at night, necessary to promote sleep onset and maintain sleep (12). Sleep dysfunctions, referring to sleep onset difficulties, are better treated with fast release MLT products, whilst those related to sleep maintenance problems are preferably treated with MLT modified release formulations (13)(14)(15)(16)(17)(18)(19)(20)(21). In this report we communicate our findings on the in vitro release of MLT from calcium alginate (CA) hydrogel beads, containing combinations of polyvinylpyrrolidone (PVP 10000 and PVP 55000 ), hydroxypropylmethylcellulose (HPMC 15000 and HPMC 100000 ), lactose monohydrate and as a surfactant sodium lauryl sulfate (SLS).…”
mentioning
confidence: 99%
“…Furthermore, polymeric beads show high bioavailability and stability. Other advantages include limited fluctuation in the therapeutic range, reduced side effects, decreased dosing frequency and improved patient compliance (21,22). Moreover, the swelling behavior in conditions, like those of gastrointestinal liquids, is a very important parameter that has to be investigated during the development of these systems for the oral administration of drugs (23).…”
mentioning
confidence: 99%